Drug intelligence / Profile preview

BiLing Zhidai

Development stage: Preclinical
Lead developer: Special Project for Scientific and Technological Research in Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

BiLing Zhidai is a traditional Chinese herbal formulation administered orally as tablets. It is being investigated for the treatment of vulvovaginal candidiasis, particularly in patients with spleen deficiency and dampness excess syndrome. Research suggests that related Zhidai Decoctions may exert their therapeutic effects by regulating the vaginal microbiota, promoting the growth of beneficial bacteria such as Lactobacillus and Staphylococcus, while reducing the abundance of pathogenic bacteria like Pasteurella and Helicobacter. This mechanism has also been explored in the context of cervical cancer.

Brand names: BiLing Zhidai
Other names: Zhidai DecoctionZDD

Beyond the preview

Go deeper on BiLing Zhidai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiLing Zhidai.

Explore the full profile